Merck & Co., Inc.
Get $10 bonus on your first $100 deposit for 6MK.DE
Get $10 bonus on your first $100 deposit for 6MK.DE
Merck & Co., Inc. (6MK.DE) Stock Competitors & Peer Comparison
See (6MK.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 6MK.DE | €99.45 | -2.40% | 245.9B | 15.94 | €6.24 | +2.79% |
| LLY.DE | €772.20 | -2.61% | 729.6B | 39.26 | €19.67 | +0.68% |
| JNJ.DE | €201.50 | -1.27% | 485.3B | 21.50 | €9.37 | +2.18% |
| 4AB.DE | €175.40 | -0.71% | 310.2B | 86.83 | €2.02 | +3.24% |
| ZEG.DE | €160.70 | +0.59% | 249.2B | 28.75 | €5.59 | +1.69% |
| AMG.DE | €293.20 | -1.30% | 158.1B | 23.99 | €12.22 | +2.78% |
| GIS.DE | €117.60 | -1.23% | 146B | 20.28 | €5.80 | +2.30% |
| PFE.F | €22.96 | -0.09% | 131.5B | 19.76 | €1.17 | +6.36% |
| PFE.DE | €22.96 | -0.69% | 130.6B | 19.79 | €1.16 | +6.35% |
| BRM.DE | €48.86 | -1.51% | 99.7B | 16.51 | €2.96 | +4.32% |
Stock Comparison
6MK.DE vs LLY.DE Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, LLY.DE has a market cap of 729.6B. Regarding current trading prices, 6MK.DE is priced at €99.45, while LLY.DE trades at €772.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas LLY.DE's P/E ratio is 39.26. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to LLY.DE's ROE of +0.98%. Regarding short-term risk, 6MK.DE is more volatile compared to LLY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.Check LLY.DE's competition here
6MK.DE vs JNJ.DE Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, JNJ.DE has a market cap of 485.3B. Regarding current trading prices, 6MK.DE is priced at €99.45, while JNJ.DE trades at €201.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas JNJ.DE's P/E ratio is 21.50. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to JNJ.DE's ROE of +0.34%. Regarding short-term risk, 6MK.DE is more volatile compared to JNJ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.Check JNJ.DE's competition here
6MK.DE vs 4AB.DE Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, 4AB.DE has a market cap of 310.2B. Regarding current trading prices, 6MK.DE is priced at €99.45, while 4AB.DE trades at €175.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas 4AB.DE's P/E ratio is 86.83. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to 4AB.DE's ROE of -3.62%. Regarding short-term risk, 6MK.DE is more volatile compared to 4AB.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.Check 4AB.DE's competition here
6MK.DE vs ZEG.DE Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, ZEG.DE has a market cap of 249.2B. Regarding current trading prices, 6MK.DE is priced at €99.45, while ZEG.DE trades at €160.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas ZEG.DE's P/E ratio is 28.75. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to ZEG.DE's ROE of +0.23%. Regarding short-term risk, 6MK.DE is more volatile compared to ZEG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.Check ZEG.DE's competition here
6MK.DE vs AMG.DE Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, AMG.DE has a market cap of 158.1B. Regarding current trading prices, 6MK.DE is priced at €99.45, while AMG.DE trades at €293.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas AMG.DE's P/E ratio is 23.99. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to AMG.DE's ROE of +0.97%. Regarding short-term risk, 6MK.DE is more volatile compared to AMG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.Check AMG.DE's competition here
6MK.DE vs GIS.DE Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, GIS.DE has a market cap of 146B. Regarding current trading prices, 6MK.DE is priced at €99.45, while GIS.DE trades at €117.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas GIS.DE's P/E ratio is 20.28. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to GIS.DE's ROE of +0.41%. Regarding short-term risk, 6MK.DE is more volatile compared to GIS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.Check GIS.DE's competition here
6MK.DE vs PFE.F Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, PFE.F has a market cap of 131.5B. Regarding current trading prices, 6MK.DE is priced at €99.45, while PFE.F trades at €22.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas PFE.F's P/E ratio is 19.76. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, 6MK.DE is more volatile compared to PFE.F. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.Check PFE.F's competition here
6MK.DE vs PFE.DE Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, PFE.DE has a market cap of 130.6B. Regarding current trading prices, 6MK.DE is priced at €99.45, while PFE.DE trades at €22.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas PFE.DE's P/E ratio is 19.79. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, 6MK.DE is more volatile compared to PFE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.Check PFE.DE's competition here
6MK.DE vs BRM.DE Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, BRM.DE has a market cap of 99.7B. Regarding current trading prices, 6MK.DE is priced at €99.45, while BRM.DE trades at €48.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas BRM.DE's P/E ratio is 16.51. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to BRM.DE's ROE of +0.39%. Regarding short-term risk, 6MK.DE is more volatile compared to BRM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.Check BRM.DE's competition here
6MK.DE vs SNW.DE Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, SNW.DE has a market cap of 97.6B. Regarding current trading prices, 6MK.DE is priced at €99.45, while SNW.DE trades at €81.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas SNW.DE's P/E ratio is 20.13. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to SNW.DE's ROE of +0.15%. Regarding short-term risk, 6MK.DE is more volatile compared to SNW.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.Check SNW.DE's competition here
6MK.DE vs BAYN.SG Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, BAYN.SG has a market cap of 40.2B. Regarding current trading prices, 6MK.DE is priced at €99.45, while BAYN.SG trades at €40.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to BAYN.SG's ROE of -0.12%. Regarding short-term risk, 6MK.DE is less volatile compared to BAYN.SG. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.Check BAYN.SG's competition here
6MK.DE vs BAYN.DE Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, BAYN.DE has a market cap of 40B. Regarding current trading prices, 6MK.DE is priced at €99.45, while BAYN.DE trades at €40.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas BAYN.DE's P/E ratio is -11.07. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to BAYN.DE's ROE of -0.12%. Regarding short-term risk, 6MK.DE is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.Check BAYN.DE's competition here
6MK.DE vs IDP.DE Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, IDP.DE has a market cap of 22.3B. Regarding current trading prices, 6MK.DE is priced at €99.45, while IDP.DE trades at €151.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas IDP.DE's P/E ratio is 20.16. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to IDP.DE's ROE of +0.07%. Regarding short-term risk, 6MK.DE is more volatile compared to IDP.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.Check IDP.DE's competition here
6MK.DE vs GS7.DE Comparison April 2026
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 245.9B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, 6MK.DE is priced at €99.45, while GS7.DE trades at €20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 15.94, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, 6MK.DE's ROE is +0.36%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, 6MK.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.Check GS7.DE's competition here